2 completed, 1 active not recruiting, 1 recruiting. 3 Phase 1, 3 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 2, Recruiting 1 |
| Phase 2 | 3 | Active not recruiting 1, Completed 1, Recruiting 1 |
| Phase 3 | 1 | Active not recruiting 1 |
Follow Laminar Pharmaceuticals: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of LAM561 Acid in Pediatric Patients With Malignant Glioma and Other Advanced Solid Tumors LAM561 - High-grade Glioma, Solid Tumor, Unspecified, Child | Phase 1 / Phase 2 | Recruiting | Laminar Pharmaceuticals | 28 | 2020-09-01 | 2025-11-20 |
| LAM561 With RT and TMZ for Adults With Glioblastoma LAM561, TMZ, RT - Primary Glioblastoma, Glioblastoma Multiforme | Phase 2 / Phase 3 | Active not recruiting | Laminar Pharmaceuticals | 144 | 2019-12-01 | 2025-11-20 |
| A Study to Evaluate the Safety of LAM561 Added to Standard of Care in Newly-diagnosed Glioblastoma Patients LAM561, RT, TMZ - Glioblastoma (GBM) | Phase 1 | Completed | Laminar Pharmaceuticals | 18 | 2018-12-04 | 2023-02-21 |
| A Phase 1/2A Study of LAM561 in Adult Patients With Advanced Solid Tumours LAM561 - Glioma, Other Solid Tumours | Phase 1 / Phase 2 | Completed | Laminar Pharmaceuticals | 54 | 2013-05-01 | 2023-02-21 |
Glioblastoma (2) · Glioma (2)
Radiotherapy (1) · Temozolomide (1)
Spain (3) · United Kingdom (2) · France (1) · Israel (1) · Italy (1) · United States (1)
Dr Ander Urruticoechea Ribate (1) · Dr Jordi Rodon (1) · Dr Juanita Lopez (1) · Dr Ricardo Fernandez Rodriguez (1) · Jordi Roma, MD (1) · Prof. Ruth Plummer, BMBCh, MRCP, Cert Me (1) · Professor Johann de Bono, MB ChB FRCP MSc PhD (1)
2018 (1)